# Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance Therapy

> **NCT00164840** · PHASE3 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 244 (estimated)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** Esomeprazole

## Key facts

- **NCT ID:** NCT00164840
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 244 (ESTIMATED)
- **Last updated:** 2010-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00164840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00164840, "Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance Therapy". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00164840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*